BE’s 5.4% Drop Doesn’t Make It Deep Value

I view today’s −5.37% move to $191.08 as understandable volatility, not a clear bargain signal; it does not change my view. Bloom’s Q3 revenue rose 138.1% to $1,236M and net margin reached 20.3%, while consensus forecasts 2027 EPS growth of 62.7% to $5.324. But that still implies 35.9x forward earnings, versus peers at roughly 25.6x–37.8x, and the current-year estimate implies 58.4x. More importantly for my valuation discipline, Q3 free cash flow was −$181M and debt/equity is 1.44. Shares are already down 19.1% over one month and 44.8% from their 52-week high, yet remain up 50.8% over 12 months. The analyst target implies upside, but not enough to offset execution and valuation risk. I stay out.